ICD-10-CM Tabular Index · Chapter 3 · FY 2027 D69

Purpura and other hemorrhagic conditions (D69) ICD-10-CM

The D69 code range covers purpura and other hemorrhagic conditions with 17 ICD-10-CM diagnosis codes. 13 of them are billable and valid for claim submission in fiscal year 2027, and the category headers group them but cannot themselves be billed.

✓ Built from the official CMS FY 2027 datasetEffective Oct 1, 2026 – Sep 30, 2027
17
Diagnosis Codes
13
Billable Codes
D69
Code Range
D65–D69
Parent Section

Type 1 Excludes

A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

ICD-10-CM

Codes in the D69 Range 17 codes · 13 billable

17 of 17 shown
  • D69 Purpura and other hemorrhagic conditionsNon-billable
  • D69.0 Allergic purpura
  • D69.1 Qualitative platelet defectsNon-billable
  • D69.11 Glanzmann thrombasthenia New
  • D69.19 Other qualitative platelet defects New
  • D69.2 Other nonthrombocytopenic purpura
  • D69.3 Immune thrombocytopenic purpura
  • D69.4 Other primary thrombocytopeniaNon-billable
  • D69.41 Evans syndrome
  • D69.42 Congenital and hereditary thrombocytopenia purpura
  • D69.49 Other primary thrombocytopenia
  • D69.5 Secondary thrombocytopeniaNon-billable
  • D69.51 Posttransfusion purpura
  • D69.59 Other secondary thrombocytopenia
  • D69.6 Thrombocytopenia, unspecified
  • D69.8 Other specified hemorrhagic conditions
  • D69.9 Hemorrhagic condition, unspecified

Clinical Terms in This Code Range

Definitions from the National Library of Medicine for conditions coded in the D69 range.

Blood Platelet Disorders

Disorders caused by abnormalities in platelet count or function.

Evans Syndrome

A rare, chronic and relapsing autoimmune disorder of unknown etiology, characterized by the presence of immune thrombocytopenia and autoimmune hemolytic anemia.

IgA Vasculitis

A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.

Purpura

Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).

Purpura, Thrombocytopenic, Idiopathic

Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

Qualitative Platelet Disorder

A group of conditions characterized by impaired platelet function, which may be suggested by clinical evidence of bleeding in the setting of a normal platelet count.

Thrombasthenia

A congenital bleeding disorder with prolonged bleeding time, absence of aggregation of platelets in response to most agents, especially ADP, and impaired or absent clot retraction. Platelet membranes are deficient in or have a defect in the glycoprotein IIb-IIIa complex (PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX).

Thrombocytopenia

A subnormal level of BLOOD PLATELETS.

About the D69 Code Range

Purpura is grouped with other bleeding conditions, platelet defects, and thrombocytopenia, meaning a low platelet count.

The categories distinguish allergic purpura (D69.0), purpura without thrombocytopenia (D69.2), and immune thrombocytopenic purpura (D69.3). D69.1 separates Glanzmann thrombasthenia from other qualitative platelet defects.

Thrombocytopenia is separated into primary (D69.4), secondary (D69.5), and unspecified (D69.6). The primary group distinguishes Evans syndrome, congenital and hereditary thrombocytopenia purpura, and other forms. The secondary group distinguishes posttransfusion purpura from other forms. D69.8 and D69.9 separate other specified bleeding conditions from an unspecified bleeding condition.

FY 2027 changes: The FY 2027 ICD-10-CM update, effective October 1, 2026, added D69.11 and D69.19 and deleted D69.1.

Questions About This Page

How many billable codes are in the D69 range?

Of the 17 codes in this range, 13 are billable and valid for claim submission from October 1, 2026 through September 30, 2027. Category header codes group them but cannot be reported on claims.

What does the D69 range classify?

The range classifies purpura and other hemorrhagic conditions. Each code links to its own reference page with billing status, MS-DRG grouping, coding notes, and clinical information.

Related References

Source: CMS FY 2027 ICD-10-CM Tabular List and order file, effective October 1, 2026 through September 30, 2027.